Behind the Money cover image

Ozempic’s unconventional origins

Behind the Money

00:00

The Origins and Unique Ownership of Novo Nordisk

This chapter discusses the origins of Novo Nordisk, a pharmaceutical company, and explores its unique ownership structure, including the role of the Novo Nordisk Foundation. It also highlights the advantages of having a controlling shareholder like a foundation and the company's ability to take a long-term view in their planning.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app